One of this year's top collegiate level pitcher's, Jonathan Gray, has tested positive for the medication Adderall. Truth remains that many will make a ton of noise about this than there needs to be. Gray will not receive a suspension during the NCAA Super Regionals as Adderall is not a banned substance. In fact, Adderall is a medication used to treat patients who suffer from ADHD (attention deficit hyperactivity disorder). However, eyebrows were raised as he does not hold a prescription for the medication.
This is such a minor issue in the grand scheme of things. So much so that it shouldn't hurt Gray's draft stock as he is still expected to be taken first overall by the Houston Astros after previously being drafted in the 13th and 10th rounds earlier in his career.
At 6-4 239, this is a player who can be credited with much of the success that the Oklahoma Sooners have had this season. He has recorded a NCAA high 138 strikeouts in 119 innings of work and is looking to build on that resume. Add to it that Gray has a 1.59 ERA for the season and it is easy to see why a player of his caliber is in high demand.
The competition comes from Stanford's ace, Mark Appel who likely will go 1-2 in the draft to be held on Thursday, June 6th. Where Gray takes an upperhand is that he possesses a higher ceiling than any of the other RHP available.
Where the issue comes in is that Gray is expected to be one of the first players taken in this year's MLB Draft. According to the bylaws of the MLB and the agreement with the Player's Union, Adderall can only be taken with a valid exemption (prescription), something 110 players were granted in 2012 alone.